BIOL Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (1 geg. 2024 @ 23:00):

BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally...

Stats
Šios dienos apimtis	486 680
Vidutinė apimtis	5.88M
Rinkos kapitalizacija	4.81M
EPS	$0 ( 2024-03-26 )
Kita pelno data	( $-0.170 ) 2024-05-09
Last Dividend	$1.152 ( 2005-06-24 )
Next Dividend	$0 ( N/A )
P/E	0
ATR14	$0.00100 (0.70%)

Insider Trading

Date	Person	Action	Amount	type
2023-09-28	Goldman Sachs Group Inc	Buy	0	Common Stock
2023-06-08	Yale Kenneth P.	Buy	502 404	Restricted Stock Unit
2023-06-08	Somerman Martha J. Dds, Phd	Buy	518 429	Restricted Stock Unit
2023-06-08	Roper Jess	Buy	512 821	Restricted Stock Unit
2023-06-08	Oloughlin Kathleen T	Buy	502 404	Restricted Stock Unit

INSIDER POWER
99.65
Last 95 transactions
Buy: 20 716 278 \| Sell: 14 318 495

Tūris Koreliacija

Ilgas: 0.06 (neutral)

Trumpas: -0.82 (strong negative)

Signal:(37.228) Neutral

BIOLASE Inc Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
FYBR	0.973
ENTA	0.969
AEY	0.969
AGRI	0.969
MBRX	0.965
EDUC	0.963
DYNT	0.963
CBSH	0.962
HTIA	0.961
FNWD	0.961

10 Labiausiai neigiamai susiję koreliacijos
HORI	-0.978
FTAA	-0.975
ABGI	-0.973
LFAC	-0.972
HCNE	-0.972
ZING	-0.971
TBSA	-0.971
LGAC	-0.971
AGGR	-0.971
HERAU	-0.97

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

BIOLASE Inc Koreliacija - Valiuta/Žaliavos

0.32
( neutral )

0.24
( neutral )

0.00
( neutral )

-0.72
( moderate negative )

BIOLASE Inc Finansinės ataskaitos

Annual	2023
Pajamos:	$49.16M
Bruto pelnas:	$16.72M (34.02 %)
EPS:	$-16.14

FY	2023
Pajamos:	$49.16M
Bruto pelnas:	$16.72M (34.02 %)
EPS:	$-16.14

FY	2022
Pajamos:	$48.46M
Bruto pelnas:	$15.91M (32.83 %)
EPS:	$-413.19

FY	2021
Pajamos:	$39.19M
Bruto pelnas:	$16.53M (42.18 %)
EPS:	$-2.75

Financial Reports:

No articles found.

BIOLASE Inc Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

BIOLASE Inc Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future

Information

First Dividend	$1.152	2004-08-12
Last Dividend	$1.152	2005-06-24
Next Dividend	$0	N/A
Payout Date	2005-07-12
Next Payout Date	N/A
# dividends	6	--
Total Paid Out	$6.91	--
Avg. Dividend % Per Year	0.00%	--
Score	1.86	--
Div. Sustainability Score	0
Div.Growth Potential Score	0
Div. Directional Score	0	--

Next Divdend (Est)
(2024-05-23)

$0 Estimate 0.00 %

Dividend Stability

0.01 Very Bad

Dividend Score

1.86

Pay Frequency

Bi-Monthly

Yearly Payout

Year	Amount	Yield
2004	$3.45	0.00%
2005	$3.45	0.00%
2006	$0	0.00%
2007	$0	0.00%
2008	$0	0.00%
2009	$0	0.00%
2010	$0	0.00%
2011	$0	0.00%
2012	$0	0.00%
2013	$0	0.00%
2014	$0	0.00%
2015	$0	0.00%
2016	$0	0.00%
2017	$0	0.00%
2018	$0	0.00%
2019	$0	0.00%
2020	$0	0.00%
2021	$0	0.00%
2022	$0	0.00%
2023	$0	0.00%
2024	$0	0.00%

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Top 10 dividend Companies for NASDAQ

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
OXLC	Dividend Royal	2023-12-14	Monthly	14	10.00%	8.50
OXSQ	Dividend Diamond	2023-12-14	Monthly	21	9.10%	8.50
QYLD	Dividend Royal	2023-11-20	Monthly	11	7.50%	8.50
PSEC	Dividend Royal	2023-12-26	Monthly	21	7.04%	8.50
SLVO	Dividend Royal	2023-11-20	Monthly	12	10.77%	8.50
GAIN	Dividend Royal	2023-12-04	Monthly	20	8.19%	8.50
GLDI	Dividend Royal	2023-11-20	Monthly	12	7.15%	8.50
HRZN	Dividend King	2023-12-18	Monthly	15	6.60%	8.45
USOI	Dividend Royal	2023-11-20	Monthly	8	16.70%	8.28
PFLT	Dividend King	2023-11-15	Monthly	14	6.50%	8.27

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.420	1.500	-8.39	-10.00	[0 - 0.5]
returnOnAssetsTTM	-0.588	1.200	-10.00	-10.00	[0 - 0.3]
returnOnEquityTTM	-3.90	1.500	-10.00	-10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	1.264	0.800	8.68	6.94	[1 - 3]
quickRatioTTM	0.613	0.800	-1.101	-0.881	[0.8 - 2.5]
cashRatioTTM	0.334	1.500	9.26	10.00	[0.2 - 2]
debtRatioTTM	0.488	-1.500	1.863	-2.79	[0 - 0.6]
interestCoverageTTM	-7.60	1.000	-3.92	-3.92	[3 - 30]
operatingCashFlowPerShareTTM	-4.65	2.00	-1.550	-3.10	[0 - 30]
freeCashFlowPerShareTTM	-5.08	2.00	-2.54	-5.08	[0 - 20]
debtEquityRatioTTM	-69.38	-1.500	-10.00	10.00	[0 - 2.5]
grossProfitMarginTTM	0.340	1.000	7.66	7.66	[0.2 - 0.8]
operatingProfitMarginTTM	-0.365	1.000	-9.30	-9.30	[0.1 - 0.6]
cashFlowToDebtRatioTTM	-0.822	1.000	-5.68	-5.68	[0.2 - 2]
assetTurnoverTTM	1.401	0.800	4.00	3.20	[0.5 - 2]
Total Score				-3.99

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-0.0218	1.000	-0.103	0	[1 - 100]
returnOnEquityTTM	-3.90	2.50	-10.00	-10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	-5.08	2.00	-1.694	-5.08	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-4.65	2.00	-1.550	-3.10	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-0.00127	1.500	-3.34	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	-0.287	1.000	-9.67	0	[0.1 - 0.5]
Total Score				-3.13

BIOLASE Inc

BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, such as cosmetic, restorative, and complex surgical applications. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; diode soft-tissue laser systems for soft tissue, pain therapy, teeth whitening, and cosmetic procedures; and Epic Hygiene laser to manage non-surgical periodontitis and enhance clinical production. It also manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces, and teeth whitening gel kits. The company sells its products through its field sales force and distributor network. The company was formerly known as BIOLASE Technology, Inc. and changed its name to BIOLASE, Inc. in 2012. BIOLASE, Inc. was founded in 1984 and is headquartered in Foothill Ranch, California.